vimarsana.com

MIAMI and PERTH, Australia, April 26, 2023 /PRNewswire/ -- Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, establishes LumaCina business unit under Bridgewest Perth Pharma in Perth, Australia. The newly created business leverages the acclaimed team and production facility recently acquired by Bridgewest Group from Pfizer (Perth) Pty Ltd, a subsidiary of Pfizer, Inc., plus the addition of newly expanded capabilities, most notably, R & D. LumaCina will commercialize sterile injectable drugs in global markets and is actively expanding its portfolio through increased production under LumaCina branding. "Our recent acquisitions in Australia are a reflection of the importance we place in meeting the growing demand for high quality pharmaceuticals, both regionally, and globally. LumaCina increases our ability to help healthcare professionals readily access quality sterile injectable medicines when they need them," said Jon Kafer, President LumaCina Jon Kafer has been appointed President of LumaCina. He also serves as Chief Commercial Officer of Bridgewest Perth Pharma Pty Ltd, a subsidiary of Bridgewest Group. "Our recent acquisitions in Australia are a reflection of the importance we place in meeting the growing demand for high quality pharmaceuticals, both regionally, and globally. LumaCina increases our ability to help healthcare professionals readily access quality sterile injectable medicines when they need them. At present about 95% of our production stays in the Australia/New Zealand region, but our growth will soon change our reach," says Kafer. "We view our role in the industry as a value creator. We tap our intrinsic entrepreneurial spirit, pumping in resources and forward-looking technology, while keeping customers close. We're building on the 20-year Pfizer Perth legacy to bring forth new jobs, increased product availability, new injectable medicines and a grand vitality to a region poised to become a global leader," says Masood Tayebi, Co-Founder and Chief Executive Officer of Bridgewest Group. Initially, LumaCina will commercialize a select portfolio of sterile injectable drugs for customers previously served by Pfizer, before Bridgewest Group's acquisition of the Perth facility."We're already in conversations with pharma companies discussing licensing opportunities to bolster our portfolio. Our stellar regulatory history across multiple regulatory agencies in many countries enables us to market products to areas where drug developers have not yet obtained licensing, adding significant value for several companies," said Kafer. About LumaCina LumaCinais a fully integrated global supplier of sterile injectable pharmaceutical drugs located in Perth Australia. The team and the facility have a 30-year history of producing high quality injectables with supply reliability and an exemplary regulatory record, most recently under the ownership of Pfizer (Perth) Pty Ltd. LumaCina is investing in technology, equipment, and expanded capabilities including R & D, growing a robust pipeline across its portfolio of essential injectable medications, spanning high potency, blow fill seal and multi format vials. LumaCina is a Bridgewest Group Portfolio Company. About Bridgewest Group Bridgewest Groupis an innovative and privately held global investment firm with over $3B in private capital. Founded in 1999, the global firm has earned a long-standing reputation for creating and scaling transformational businesses to achieve outsized success. Bridgewest Group leverages its expertise and global eco-community in key sectors where it can have the greatest impact including Life Sciences, Software, Semiconductor and Artificial Intelligence/Deep Tech. Customized financial investment services and diverse real estate holdings augment equity assets and support portfolio companies as they grow. Bridgewest Group is based in the US, with investments primarily in the US, Europe, China, and Australasia. US Media Contact: Jenny Bourbiel, jbourbiel@bridgewestgroup.com Australia Media Contact: Ian Wisenberg, iwisenberg@bridgewestgroup.com Photo - https://mma.prnasia.com/media2/2062222/Bridgewest_Group_Jon_Kafer.jpg?p=medium600 Logo - https://mma.prnasia.com/media2/1850792/Bridgewest_Group_Logo.jpg?p=medium600

Related Keywords

Perth ,Western Australia ,Australia ,New Zealand ,Miami ,Florida ,United States ,China ,Jenny Bourbiel ,Jon Kafer ,Masood Tayebi ,Ian Wisenberg ,Pfizer ,Life Sciences ,Perth Pharma Pty Ltd ,Pfizer Inc ,Bridgewest Group Portfolio Company ,Bridgewest Group ,Pfizer Perth Pty Ltd ,Bridgewest Perth Pharma ,Pty Ltd ,Chief Commercial Officer ,Bridgewest Perth Pharma Pty Ltd ,Pfizer Perth ,Chief Executive Officer ,Bridgewest Group Portfolio ,Media Contact ,Miami And Perth ,April 26 ,023 Prnewswire Global Private Investment Firm ,Ecognized For Developing Innovative Companies In Life Sciences ,Software ,Nd Deep Tech ,Stablishes Lumacina Business Unit Under Bridgewest Perth Pharma In ,Ustralia The Newly Created Business Leverages Acclaimed Team And Production Facility Recently Acquired By Bridgewest Group From Pfizer Perth Pty Ltd ,A Subsidiary Of Pfizer ,Nc ,Lus The Addition Of Newly Expanded Capabilities ,Most Notably ,R Ampd Lumacina Will Commercialize Sterile Injectable Drugs In Global Markets And Is Actively Expanding Its Portfolio Through Increased Production Under Branding Quot Our Recent Acquisitions Australia Area Reflection Of The Importance We Place Meeting Growing Demand For High Quality Pharmaceuticals ,Oth Regionally ,Nd Globally Lumacina Increases Our Ability To Help Healthcare Professionals Readily Access Quality Sterile Injectable Medicines When They Need Them ,Uot Said Jon Kafer ,Resident Lumacina Jon Kafer Has Been Appointed President Of He Also Serves As Chief Commercial Officer Bridgewest Perth Pharma Pty Ltd ,A Subsidiary Of Bridgewest Group Quot Our Recent Acquisitions In Australia Area Reflection The Importance We Place Meeting Growing Demand For High Quality Pharmaceuticals ,Nd Globally Lumacina Increases Our Ability To Help Healthcare Professionals Readily Access Quality Sterile Injectable Medicines When They Need Them At Present About 95 Of Production Stays In The Australia New Zealand Region ,Ut Our Growth Will Soon Change Reach ,Uot Says Kafer Quot We View Our Role In The Industry Asa Value Creator Tap Intrinsic Entrepreneurial Spirit ,Umping In Resources And Forward Looking Technology ,Hile Keeping Customers Close We 39 Re Building On The 20 Year Pfizer Perth Legacy To Bring Forth New Jobs ,Ncreased Product Availability ,Ew Injectable Medicines Anda Grand Vitality Toa Region Poised To Becomea Global Leader ,Uot Says Masood Tayebi ,O Founder And Chief Executive Officer Of Bridgewest Group Initially ,Umacina Will Commercializea Select Portfolio Of Sterile Injectable Drugs For Customers Previously Served By Pfizer ,Efore Bridgewest Group 39s Acquisition Of The Perth Facility Quot We 39 Re Already In Conversations With Pharma Companies Discussing Licensing Opportunities To Bolster Our Portfolio Stellar Regulatory History Across Multiple Agencies Many Countries Enables Us Market Products Areas Where Drug Developers Have Not Yet Obtained ,Dding Significant Value For Several Companies ,Uot Said Kafer About Lumacina Lumacinaisa Fully Integrated Global Supplier Of Sterile Injectable Pharmaceutical Drugs Located In Perth Australia The Team And Facility Havea 30 Year History Producing High Quality Injectables With Supply Reliability An Exemplary Regulatory Record ,Ost Recently Under The Ownership Of Pfizer Perth Pty Ltd Lumacina Is Investing In Technology ,Equipment ,Nd Expanded Capabilities Includingr Amp D ,Rowinga Robust Pipeline Across Its Portfolio Of Essential Injectable Medications ,Panning High Potency ,Low Fill Seal And Multi Format Vials Lumacina Isa Bridgewest Group Portfolio Company About Groupis An Innovative Privately Held Global Investment Firm With Over 3b In Private Capital Founded 1999 ,He Global Firm Has Earneda Long Standing Reputation For Creating And Scaling Transformational Businesses To Achieve Outsized Success Bridgewest Group Leverages Its Expertise Eco Community In Key Sectors Where It Can Have The Greatest Impact Including Life Sciences ,Emiconductor And Artificial Intelligence Deep Tech Customized Financial Investment Services Diverse Real Estate Holdings Augment Equity Assets Support Portfolio Companies As They Grow Bridgewest Group Is Based In The Us ,Ith Investments Primarily In The Us ,Europe ,Nd Australasia Us Media Contact Jenny Bourbiel ,Bourbiel Bridgewestgroup Com Australia Media Contact Ian Wisenberg ,Wisenberg Bridgewestgroup Com Photo Https Mma Prnasia Media2 2062222 Bridgewest Group Jon Kafer Jpgp Medium600 Logo 1850792 ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.